glp 1 agonist weight loss mechanism and Maintenance Related to the of Action of Glucagon-Like Peptide Receptor Agonists | Advances in Therapy GLP-1 Therapy Part 1: Setting

10.2337/dc14-1625 33 GoswamiC.IwasakiY.YadaT

Effects of dapagliflozin on development and progression of kidney disease in patients with type 2 diabetes: an analysis from the DECLARE-TIMI 58 randomised trial

Further, direct stimulation of the GLP-1 receptor on cholangiocytes can lead to enhanced cellular proliferation and an elevated likelihood of cholestasis [47]

Arguments for Game Changer Status Several compelling arguments support the characterization of GLP-1 agonists as transformative therapies: Unprecedented Efficacy : Tirzepatide marks a new era in overweight/obesity treatment, enabling many to achieve 20% weight loss [76] [77]

Published August 2, 2023